Elder Law & Estate Planning
Request Consultation

Medicare Prescription Drug Coverage (Part D)

Medicare offers a federally subsidized drug program for seniors, in which private health insurers offer limited insurance coverage of prescription drugs to elderly and disabled Medicare recipients. The drug benefit is available only through insurers that contract with Medicare to market drug plans.

Posted on July 17, 2019

What does the drug benefit cost and what do you get?

Medicare recipients who elect to be covered by the drug benefit will pay premiums averaging $41.21 a month in 2019. This is an average; some plans will charge more, some less.

After meeting a $435 (in 2020) deductible, you will pay 25 percent of drug costs up to $4,020 (in 2020) in a year, with Medicare footing the bill for the other 75 percent. The plan will pay $3,015 and you will pay $1,005. Previously coverage stopped completely at this point until total out-of-pocket spending reached a certain amount. (This coverage gap is sometimes called the “doughnut hole”.) However, the Affordable Care Act is slowly eliminating the doughnut hole. In 2020, until your total out-of-pocket spending reaches $6,350, you’ll pay 25 percent for brand-name drugs and 37 percent for generic drugs. Although you will be paying a discounted rate for drugs, the total cost of the drug will count toward your out-of-pocket costs. Once total spending for your covered drugs exceeds $6,350 (called “catastrophic coverage”), you are out of the coverage gap and you will only pay a small co-payment or co-insurance amount. These discounts and Medicare coverage gradually increase until 2020 when the doughnut hole is fully closed. For more information, click here.

The amount of out-of-pocket costs that you have to pay to reach catastrophic coverage will vary, depending on the type of drugs you take. For brand name drugs, you will only pay a certain percent of the price, but the entire price will count toward the amount you need to qualify for catastrophic coverage. With generic drugs, only the amount you pay will count toward getting you out of the doughnut hole. For more information about the coverage gap, click here.

One way to avoid the coverage gap is to pick a plan with low drug prices, since it is accumulating drug costs that brings you closer to the gap — not low premiums, co-payments, or deductibles. (We are describing Medicare’s basic prescription drug coverage, which all insurers must offer. Insurers may also offer more generous coverage and charge a higher premium for it.) AARP has created a calculator for beneficiaries to determine how to avoid the doughnut hole.

Bear in mind that only payments for drugs that are covered by your plan (see below) count towards the out-of-pocket threshold. Also, any help with paying for Medicare Part D costs that you receive from an employer health plan or other insurance does not count toward this limit. Drugs purchased abroad (such as from Canada) will not be covered by the Medicare benefit and will not count toward the out-of-pocket limit.

Will drugs you take be covered?

All Part D enrollees should have at least two Medicare private drug plans to choose from. The insurers choose the medicines — both brand-name and generic — that they will include in a plan’s “formulary,” the roster of drugs the plan covers and will pay for. However, each plan formulary must include at least two drugs in each drug class, and must cover a majority of the drugs in certain classes, such as antidepressants and anti-cancer agents.

Since each drug plan offers a different formulary, and the same drug may vary in price from plan to plan, the most important job for a Medicare beneficiary signing up for Part D is to determine whether the prescription drugs they need or anticipate needing — are covered under a particular plan and how much they cost.

Plans differ in the monthly premiums they charge, deductibles, the drugs they cover, the cost of those drugs, limitations on drug purchases, and the convenience of the plan’s pharmacy network, among other factors. A comparison tool is available on Medicare’s Web site that allows you to search for Medicare private drug plans in your region and compare their costs, covered drugs and pharmacy networks. The information is also available by calling 1-800-MEDICARE. In addition, the Medicare & You handbook provides information about the Medicare private drug plans in your area.

But it’s possible that all your diligent research could come to nothing because after you have enrolled in what seems to be the best plan, the plan may discontinue coverage or increase the cost of any particular drug! Can you then switch plans? Only those eligible for both Medicare and Medicaid (see below) may switch plans whenever they want. Other beneficiaries will be locked into their choice for a full year; however, you won’t lose coverage for any drugs you are currently taking. If a company drops coverage for a drug, it must continue to cover participants currently taking that drug until the end of the year. There are some exceptions — for example, if the drug is determined to be unsafe or a lower-cost generic drug comes on the market.

Medicare Part D does not cover certain drugs, including barbiturates and benzodiazepines, which are prescribed for older people to treat insomnia, seizure disorders, anxiety, panic attacks, and muscle spasms. States have the option of providing Medicaid coverage for the excluded drugs.

Each Medicare drug plan will likely give you a list of local pharmacies where you can obtain their covered drugs.

Who may enroll?

Anyone who has either Medicare Part A or Medicare Part B (or both) can get Medicare Part D, Medicare’s prescription drug coverage. Bear in mind, however, that Medicare Part D will not pay for drugs that could have been paid for under Medicare Part A or Medicare Part B. These drugs will not be covered even if the beneficiary does not have either Part A or Part B.

When should you enroll?

To avoid a penalty, you need to enroll during your Initial Enrollment Period (IEP). Your IEP for Part D is the same as for Part B. It is a seven-month period that includes the three months before the month you become eligible, the month you are eligible and three months after the month you become eligible.

How do you enroll?

Once you have chosen the Medicare private drug plan you want to enroll in, you can contact the company offering the plan and ask for a paper application, or complete an online application on the plan’s Web site, if the plan allows online applications. The online application also may be available on Medicare’s Web site.

If you cannot enroll yourself, a representative who is authorized under state law can enroll for you. This could include a health care proxy, an agent acting under a power of attorney, or another surrogate decision maker as defined by state law.

If you are in a Medicare HMO or PPO, you can enroll in a plan offered by the company that sponsors your Medicare health plan.

Late enrollment penalties

Medicare beneficiaries may be subject to significant financial penalties for late enrollment. For every month you delay enrollment past the Initial Enrollment Period, the Medicare Part D premium will increase at least 1 percent. For example, if the premium is $40 a month, and you delay enrollment for 15 months, your premium penalty would be $6 (1 percent x 15 x $40 = $6), meaning that you would pay $46 a month, not $40, for coverage that year and an extra $6 a month each succeeding year.

Beneficiaries are exempt from these penalties if they did not enroll because they had drug coverage from a private insurer, such as through a retirement plan, at least as good as Medicare’s. This is called “creditable coverage. Your insurer should have let you know if their coverage will be considered creditable.

Restrictions on drug plan marketing

As noted, billions of dollars are at stake in convincing Medicare recipients to sign up for this benefit. The Centers for Medicare & Medicaid Services (CMS) has issued marketing guidelines for companies offering prescription drug plans. Approved drug plans are prohibited from making door-to-door sales calls or sending unsolicited e-mails. Plans also must comply with the National Do-Not-Call Registry rules, honor “do not call again” requests, and abide by federal and state calling hours and any other relevant requirements. (Federal rules do not allow telemarketers to call before 8 a.m. or after 9 p.m. State rules may differ.)

Plan marketing representatives are not allowed to request personal information such as Social Security Numbers, bank account numbers, or credit card numbers.

Beware of scams

Con artists use the drug benefit as a wedge to convince unsuspecting Medicare recipients to part with personal information like bank account numbers. Residents of at least 13 states have reported a scam in which criminals attempt to sell fake Medicare prescription drug cards for the Part D benefit. Since plans can’t market until October, any contacts before that time are suspect. Anyone who is unsure about a contact should call Medicare at 1-800-MEDICARE.

Social Security will be contacting low-income Medicare recipients who have incomplete applications or who haven’t sent one in. Social Security representatives generally will not ask for Social Security numbers, bank account numbers, credit card numbers or life insurance policy numbers. If beneficiaries are unsure a caller is really from Social Security, they can verify the call by contacting the agency at 1-800-772-1213.

For more information . . .

The Medicare drug benefit is a complicated program (the program’s rules and explanatory materials run to 1,172 pages). No single article can address all the questions or issues that beneficiaries may have. Following are some sources for more detailed information:

Medicare & You Handbook, Centers for Medicare & Medicaid Services.

Choosing a Medicare Prescription Drug Plan, The Medicare Rights Center

The Center for Medicare Advocacy’s Medicare Part D page.

Definitions of Selected Health Insurance Terminology Under Medicare Part D, Center for Medicare Advocacy, Inc.

AARP’s Drug Benefit Calculator

Resources on the Medicare Prescription Drug Benefit, Kaiser Family Foundation.

(Some of the above documents are in PDF format. If you do not have the free PDF reader installed on your computer, download it here.)

Have further questions about Medicare? The Medicare Rights Center operates a toll-free hotline where you can get answers from counselors. The hotline is open Monday through Thursday, 9am-2pm Eastern Time. Call (800) 333-4114.

More from our blog...

Person sitting alone at a table with documents and a window view representing aging alone estate planning in New Jersey

Aging Alone: What to Do Legally and Financially When There Is No Spouse or Partner to Plan With

September 13, 2026
According to the Pew Research Center, roughly 26 percent of Americans ages 65 and older lived alone in 2023. Census Bureau research has also found…
Close-up of lush green leaves representing the idea that estate planning documents are built for living, not just for what happens at death.

Estate Planning Is Built Around Death. But What About Everything That Comes Before It?

September 10, 2026
A recent Forbes article by John Samuels, founder and CEO of the healthcare advisory firm Wellworth, makes a case that the estate planning industry has…
lose-up of a weathered brick wall with the words "Step-Up In Basis" — what the step-up in basis rule means for inherited property and how it affects capital gains taxes in New Jersey

What Is a Step-Up in Basis and Why Does It Matter When You Inherit?

September 4, 2026
When you inherit a piece of real estate or a brokerage account, the tax basis of that asset is generally adjusted to its fair market…
Shadows of a multigenerational family walking together on pavement with the words "While There Is Time" — what families in New Jersey should do legally and financially as parents get older

My Parents Are Getting Older. What Should We Be Doing Now?

August 31, 2026
The worry usually arrives quietly. A parent forgets something they would not have forgotten before. A bill goes unpaid. A conversation reveals that they have…
Back To blog

Table of Contents

FREE WEBINAR

5 Things to Know About

Estate Planning

When You Turn Sixty-Five


    Save the Date

    Friday, Sep 18th at 2:30pm

    Privacy Policy

    This Privacy Statement describes how Milvidskiy Law Group P.C. collects, uses, and discloses certain personal information obtained through our public web site at www.milvidlaw.com (the “Web Site”). This Privacy Statement does not address information collection through other sources such as in-person seminars, workshops, or in-person consultations and contacts.

    SMS Privacy Policy

    Milvidskiy Law Group P.C. may disclose Personal Data and other information as follows:

    Third Parties that Help Provide the Messaging Service: We will not share your opt-in to an SMS short code campaign with a third party for purposes unrelated to supporting you in connection with that campaign. We may share your Personal Data with third parties that help us provide the messaging service, including, but not limited to, platform providers, phone companies, and other vendors who assist us in the delivery of text messages.

    Additional Disclosures: Affiliates: We may disclose the Personal Data to our affiliates or subsidiaries; however, if we do so, their use and disclosure of your Personal Data will be subject to this Policy. All the above categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties.

    Personal Information Collection and Use

    In general, you can visit our Web Site without telling us who you are or revealing any information about yourself. There are times, however, when we ask for personally identifiable information from you, such as your name, company, e-mail address, phone number, and address (“Personal Information”). We request this information in order to correspond with you, to provide you with a subscription to a newsletter or publication, to notify you about events, or otherwise to respond to your requests or provide you with information that we consider may be of interest to you. Where applicable, we will differentiate between personal data fields that are optional and those that are mandatory to obtain the requested information.

    If you receive a marketing e-mail from Milvidskiy Law Group P.C., you will be provided with an automated way to opt out (unsubscribe) from that particular communication or from all marketing e-mails sent by our firm. Please follow the instructions on the e-mail you received. If you have received unwanted e-mail from our firm, please forward a copy of that e-mail to [email protected].

    Please note that if you reply to a Milvidskiy Law Group P.C. address in one of our marketing e-mails or otherwise send a communication to us, your communication will not create an attorney-client relationship with us. Do not send us any information that you or anyone else considers to be confidential or secret unless we have first agreed to be your lawyers in that matter. Any information you send us before we agree to be your lawyers cannot be protected from disclosure.

    Data Sharing

    We may share Personal Information among our member attorneys for purposes of responding to your requests or otherwise as necessary for the purposes described above. We may also in limited circumstances share Personal Information with government authorities or others as required to protect the interests of the firm or others, as necessary in connection with the sale or transfer of all or a portion of the business, or as required by applicable law or court order.

    International Data Transfers

    This Web Site is hosted on a web server in the United States. If you are located in a non-US jurisdiction, your provision of Personal Information or other access to our Web Site constitutes your transfer of such data to the United States, a jurisdiction that may not provide a level of data protection equivalent to the laws in your home country.

    Security Measures

    Milvidskiy Law Group P.C. maintains appropriate technical and organizational security measures to protect the security of your Personal Information against the loss, misuse, unauthorized access, disclosure or alteration.

    Links to Other Web Sites

    The privacy practices set forth in this Privacy Statement are for our web site only. This web site may contain links to other sites. Milvidskiy Law Group P.C. is not responsible for the privacy practices or the content of such sites. If you link to or otherwise visit any other site, please review the privacy policies posted at that site.

    Cookies and Passive Tracking

    A “cookie” is an element of data that can be sent to your browser. Your browser may then store it on your system based on the preferences you have set on your browser. Cookies gather information about your operating system including, but not limited to, browser type, and Internet Protocol (IP) address. The Web Site uses this information to analyze the traffic on our web site, and better serve you when you return to our web site. It is not our intention to use such information to personally identify a user. You have the option to configure your Internet browser to notify you when you receive a cookie, giving you the chance to decide whether to accept it. Further, you have the option to block all cookies. Please note, however, that if you refuse or otherwise block cookies you may not be able to use all of the functionality available on the web site.

    Access and Correction

    If you wish to access or update the Personal Information you submit through our web site, or to make any inquiries about the processing of such information, please contact us as described below. We provide individuals with access to their Personal Information where we believe appropriate, including in situations where you are entitled to access and review your Personal Information under applicable data protection and privacy laws.

    Google ReCaptcha Spam Protection

    This site is protected by reCAPTCHA and the Google.
    Privacy Policy and
    Terms of Serice apply.

    Revisions to this Privacy Statement

    Milvidskiy Law Group P.C. reserves the right to change this Privacy Policy from time to time. Please check the Privacy Statement frequently and particularly before you submit additional personal information via the Web Site. All revisions to this Privacy Statement will be posted on the web site via a link from the homepage. We also display the effective date of the Privacy Statement on the top of this page.

    Close

    Disclaimer

    Attorney Advertising. The information presented on this website is for informational purposes only and should not be construed as a legal advice. Viewing of, responding to, or otherwise transmitting the information on this website is not intended to create, and receipt of the same does not constitute, an attorney-client relationship. The information provided on this website should not be relied upon without first seeking professional legal counsel. The information on this website is provided only as general information which may or may not reflect the most current developments of law. Prior results and cases discussed on this website do not imply and do not guarantee a similar outcome in any other case. The links to other websites contained herein do not constitute a referral or endorsement of any kind.
    Close
    Sign up for our newsletter to be updated on all the latest news in Elder Law and Estate Planning.

      Every plan starts with a conversation. Tell us a little about your situation, and our Client Services Coordinator will reach out to help you schedule your consultation.

        This site is protected by reCAPTCHA and the Google.
        Privacy Policy and Terms of Service apply.

        Open chat Call us Close chat
        Start a conversation
        Team member Team member Team member
        Contact us to protect what matters most to you and your loved ones